MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxia"

  • 2017 International Congress

    A comparative study between OCT in SCA3 and 10

    F. Tensini, M. Sato, N. Shiokawa, H. Teive (Curitiba, Brazil)

    Objective: To describe OCT findings in spinocerebellar ataxia (SCA) type 10, correlate it with expansion size and disease severity and compare with those of SCA3…
  • 2017 International Congress

    Quantitative evaluation of gait ataxia by triaxial accelerometers is more sensitive than SARA within 1.5 years.

    S. Shirai, I. Yabe, M. Matsushima, Y. Ito, M. Yoneyama, H. Sasaki (Sapporo, Japan)

    Objective: An appropriate biomarker for spinocerebellar degeneration (SCD) is needed. Background: Previously we reported that the average amplitude of medial-lateral of straight gait gained by…
  • 2017 International Congress

    Early diagnosis in Spinocerebellar Ataxias: Prospects for clinical alterations and ethical dilemmas during preclinical trials.

    L. Velázquez-Pérez, R. Rodríguez-Labrada, J. Rodríguez-Diaz, Y. Vazquez-Mojena, J. Medrano-Montero, A. Estupiñán-Rodríguez (Holguín, Cuba)

    Objective: To assess the acceptation level and ethical concerns for participating in early intervention approaches in Spinocerebellar Ataxia type 2 preclinical carriers and to evaluate…
  • 2017 International Congress

    TANDEM REPEATS BEYOND THE CLINICAL DIAGNOSIS IN ADCAs

    A. Srivastava, M. Faruq, S. Shakya, I. Singh, V. Swarup (New Delhi, India)

    Objective: To present observations on abnormal expansion in both allele in ADCAs. Background: Use of expansion in tandem repeats is restricted to only disease diagnosis…
  • 2017 International Congress

    Effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration.

    T. Shimizu, R. Hanajima, R. Tsutsumi, K. Shimizu, N. Tominaga, Y. Ugawa, K. Nishiyama (Sagamihara, Japan)

    Objective: To reveal effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration (SCD). Background: TRH [Thyrotropin releasing hormone (protirelin tartrate)]…
  • 2017 International Congress

    Prof. Wadia’s contributions to neurology and SCA2

    F. Tensini, J. Pedroso, O. Barsottini, H. Teive (Curiitiba, Brazil)

    Objective: To present a review of the seminal contributions of Professor Wadia to neurology, in particular the first description of SCA2. Background: Spinocerebellar ataxia type…
  • 2017 International Congress

    Focal dystonia as an early symptom of CACNA1A mutation: case report and literature review.

    Y. Gu, K. Kumar, C. Sue (Sydney, Australia)

    Objective: We describe two cases, a father-daughter pair, of CACNA1A mutation with task specific dystonia as an early feature. The father otherwise had a phenotype…
  • 2016 International Congress

    A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India

    S. Chatterjee, R. Banerjee, B. Mondal, M.U. Kulsum, K. Chatterjee, S.S. Jha, P. Chatterjee, S. Choudhury, S.S. Anand, H. Kumar (Kolkata, India)

    Objective: To study phenotype and Quality of life determinant in patients with SCA-12. Background: Spinocerebellar ataxia type 12 (SCA-12) is an extremely rare autosomal dominant,…
  • 2016 International Congress

    Testing candidate transcriptional biomarkers of asymtpomatic and symptomatic stages in spinocerebellar ataxia type 3 (SCA3)

    M. Raposo, C. Bettencourt, M. Lima (Ponta Delgada, Portugal)

    Objective: To investigate the potential of nine candidate genes as transcriptional biomarkers of asymptomatic and symptomatic stages of spinocerebellar ataxia type 3 (SCA3). Background: An…
  • 2016 International Congress

    Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree

    P. Bogdanova-Mihaylova, N. Austin, M.D. Alexander, L. Cassidy, S.M. Murphy, R.A. Walsh (Dublin, Ireland)

    Objective: We report on a family with ataxia due to mutations in the ANO10 gene to provide comprehensive clinical and cognitive data on the associated…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Fasciculations from a cholinesterase inhibitor
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley